Cash Flow Statement (Annual)

ENUM / Enumeral Biomedical Holdings, Inc. Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.

All numbers are times 1,000 except per share units.

2013 2014 2015 2016
Net Cash Provided By Used In Operating Activities
  Net Income Loss -3,865 -8,179 3,290 -11,856
  Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
    Depreciation And Amortization 281 304 617 609
    Share Based Compensation 367 659 827 932
    Warrant Expense - - - -
    Gain Loss On Disposition Of Assets - - - -
    Other Noncash Expense - - - -
    Accretion Of Debt Discount And Issuance Costs - - - -
    Derivative Gain Loss On Derivative Net -3 184 13,981 1,608
  Increase Decrease In Operating Capital
    Increase Decrease In Accounts Receivable 71 159 22 -117
    Increase Decrease In Prepaid Deferred Expense And Other Assets 59 62 184 -236
    Increase Decrease In Restricted Cash - - - -
    Increase Decrease In Accounts Payable Trade - - -270 -35
    Increase Decrease In Accrued Liabilities 68 53 497 -328
    Increase Decrease In Other Deferred Liability - - 4 26
    Increase Decrease In Deferred Revenue -48 210 -106 -116
  Net Cash Provided By Used In Operating Activities -3,309 -5,238 -9,285 -
Net Cash Provided By Used In Investing Activities
  Payments To Acquire Property Plant And Equipment 63 564 1,051 -
  Proceeds From Sale Of Property Plant And Equipment - - - -
  Net Cash Provided By Used In Investing Activities -63 -4,113 1,978 -
Net Cash Provided By Used In Financing Activities
  Issuance Of Promissory Notes - - - -
  Payments To Acquire Equipment On Lease - - - 240
  Net Cash Provided By Used In Financing Activities 1,888 19,548 443 -
Cash And Cash Equivalents Period Increase Decrease -1,484 10,196 -6,864 -434
Cash And Cash Equivalents At Carrying Value - 10,460 3,596 3,162
Supplemental Cash Flow Information
  Interest Paid Net - - - -
  Use Of Security Deposit For Lease Buyout - - - -
  Debt Discount Associated With2017 Unit Offering - - - -

Peers - Pharmaceutical Preparations (2834)

CUSIP: 294017108